A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Bio Restorative Therapies, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 20,000 shares of BRTX stock, worth $31,000. This represents 0.0% of its overall portfolio holdings.

Number of Shares
20,000
Holding current value
$31,000
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$1.32 - $1.98 $26,400 - $39,600
20,000 New
20,000 $34,000
Q1 2024

May 13, 2024

BUY
$1.28 - $3.45 $31,822 - $85,770
24,861 New
24,861 $34,000

Others Institutions Holding BRTX

About BioRestorative Therapies, Inc.


  • Ticker BRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 3,650,030
  • Market Cap $5.66M
  • Description
  • BioRestorative Therapies, Inc., a life sciences company, focuses on the development of regenerative medicine products and therapies using cell and tissue protocols primarily involving adult stem cells. The company's two core developmental programs relate to the treatment of disc/spine disease and metabolic disorders. Its disc/spine program (brtx...
More about BRTX
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.